• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FBXO22 降解核内 PTEN 以促进肿瘤发生。

FBXO22 degrades nuclear PTEN to promote tumorigenesis.

机构信息

Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, State Key Laboratory of Oncogenes and Related Genes and Chinese Academy of Medical Sciences Research Unit (NO.2019RU043), Shanghai Cancer Institute, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.

Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 200025, Shanghai, China.

出版信息

Nat Commun. 2020 Apr 6;11(1):1720. doi: 10.1038/s41467-020-15578-1.

DOI:10.1038/s41467-020-15578-1
PMID:32249768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7136256/
Abstract

Nuclear localization of PTEN is essential for its tumor suppressive role, and loss of nuclear PTEN is more prominent than cytoplasmic PTEN in many kinds of cancers. However, nuclear PTEN-specific regulatory mechanisms were rarely reported. Based on the finding that nuclear PTEN is more unstable than cytoplasmic PTEN, here we identify that F-box only protein 22 (FBXO22) induces ubiquitylation of nuclear but not cytoplasmic PTEN at lysine 221, which is responsible for the degradation of nuclear PTEN. FBXO22 plays a tumor-promoting role by ubiquitylating and degrading nuclear PTEN. In accordance, FBXO22 is overexpressed in various cancer types, and contributes to nuclear PTEN downregulation in colorectal cancer tissues. Cumulatively, our study reports the mechanism to specifically regulate the stability of nuclear PTEN, which would provide the opportunity for developing therapeutic strategies aiming to achieve complete reactivation of PTEN as a tumor suppressor.

摘要

PTEN 的核定位对于其肿瘤抑制作用至关重要,在许多癌症中,核 PTEN 的丢失比细胞质 PTEN 更为突出。然而,核 PTEN 特异性的调节机制很少有报道。基于核 PTEN 比细胞质 PTEN 更不稳定的发现,我们在这里确定 F-box 仅蛋白 22(FBXO22)在赖氨酸 221 处诱导核而非细胞质 PTEN 的泛素化,这负责核 PTEN 的降解。FBXO22 通过泛素化和降解核 PTEN 发挥促进肿瘤的作用。相应地,FBXO22 在各种癌症类型中过表达,并有助于结直肠癌组织中核 PTEN 的下调。总之,我们的研究报告了专门调节核 PTEN 稳定性的机制,这为开发旨在完全重新激活作为肿瘤抑制因子的 PTEN 的治疗策略提供了机会。

相似文献

1
FBXO22 degrades nuclear PTEN to promote tumorigenesis.FBXO22 降解核内 PTEN 以促进肿瘤发生。
Nat Commun. 2020 Apr 6;11(1):1720. doi: 10.1038/s41467-020-15578-1.
2
Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.敲低 FBXO22 通过 HIF-1α/VEGF 通路抑制黑色素瘤细胞迁移、侵袭和血管生成。
Invest New Drugs. 2020 Feb;38(1):20-28. doi: 10.1007/s10637-019-00761-z. Epub 2019 Mar 18.
3
FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.FBXO22,一种表观遗传多效协调衰老、激素信号和转移的蛋白。
Cancer Sci. 2020 Aug;111(8):2718-2725. doi: 10.1111/cas.14534. Epub 2020 Jul 17.
4
F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.F-box蛋白FBXO22介导KLF4的多聚泛素化和降解,以促进肝细胞癌进展。
Oncotarget. 2015 Sep 8;6(26):22767-75. doi: 10.18632/oncotarget.4082.
5
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.FBXO22 通过调控 p21 的泛素化降解促进肝细胞癌的发展。
J Exp Clin Cancer Res. 2019 Feb 26;38(1):101. doi: 10.1186/s13046-019-1058-6.
6
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.Fbxo22 介导的 KDM4B 降解决定了选择性雌激素受体调节剂在乳腺癌中的活性。
J Clin Invest. 2018 Dec 3;128(12):5603-5619. doi: 10.1172/JCI121679. Epub 2018 Nov 12.
7
FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.FBXO22 通过抑制 MMP-9 介导的迁移和侵袭以及 VEGF 介导的血管生成抑制人肾细胞癌的转移。
Int J Biol Sci. 2019 Jan 24;15(3):647-656. doi: 10.7150/ijbs.31293. eCollection 2019.
8
FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.N-甲基-D-天冬氨酸(NMDA)受体协同激动剂D-丝氨酸的最佳合成需要FBXO22蛋白。
J Biol Chem. 2014 Dec 5;289(49):33904-15. doi: 10.1074/jbc.M114.618405. Epub 2014 Oct 21.
9
SCF targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.SCF 靶向 HDM2 进行降解,并调节乳腺癌细胞的侵袭和转移。
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11754-11763. doi: 10.1073/pnas.1820990116. Epub 2019 May 28.
10
F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.F盒蛋白FBXO22介导CD147的多聚泛素化和降解以逆转肿瘤细胞的顺铂耐药性。
Int J Mol Sci. 2017 Jan 20;18(1):212. doi: 10.3390/ijms18010212.

引用本文的文献

1
Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22.降解剂的开发以及2-吡啶甲醛(2-PCA)作为FBXO22的募集配体
bioRxiv. 2025 Aug 20:2025.08.19.671158. doi: 10.1101/2025.08.19.671158.
2
Role and therapeutic potential of the NEDD4 family in breast cancer.NEDD4家族在乳腺癌中的作用及治疗潜力
Front Pharmacol. 2025 Jun 4;16:1587675. doi: 10.3389/fphar.2025.1587675. eCollection 2025.
3
BRD4 regulates mA of ESPL1 mRNA interaction with ALKBH5 to modulate breast cancer progression.

本文引用的文献

1
Multiple roles of PTEN isoforms PTENα and PTENβ in cellular activities and tumor development.PTEN亚型PTENα和PTENβ在细胞活动和肿瘤发展中的多种作用。
Sci China Life Sci. 2019 Dec;62(12):1722-1724. doi: 10.1007/s11427-019-1595-2. Epub 2019 Dec 1.
2
PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.PTENα 和 PTENβ 通过 WDR5 和 H3K4 三甲基化促进致癌作用。
Nat Cell Biol. 2019 Nov;21(11):1436-1448. doi: 10.1038/s41556-019-0409-z. Epub 2019 Nov 4.
3
Grb2 binds to PTEN and regulates its nuclear translocation to maintain the genomic stability in DNA damage response.
BRD4通过调控ESPL1 mRNA的m⁶A修饰以及与ALKBH5的相互作用来调节乳腺癌进展。
Acta Pharm Sin B. 2025 Mar;15(3):1552-1570. doi: 10.1016/j.apsb.2024.12.037. Epub 2025 Jan 3.
4
Cullin-RING Ubiquitin Ligases in Neurodevelopment and Neurodevelopmental Disorders.神经发育及神经发育障碍中的Cullin-RING泛素连接酶
Biomedicines. 2025 Mar 28;13(4):810. doi: 10.3390/biomedicines13040810.
5
SDCBP/Syntenin-1 stabilizes BACH1 by disassembling the SCF-BACH1 complex in triple-negative breast cancer.在三阴性乳腺癌中,SDCBP/连接蛋白-1通过拆解SCF-BACH1复合物来稳定BACH1。
EMBO J. 2025 Apr 22. doi: 10.1038/s44318-025-00440-1.
6
PRMT7-Mediated PTEN Activation Enhances Bone Regeneration in Female Mice.PRMT7介导的PTEN激活增强雌性小鼠的骨再生。
Int J Mol Sci. 2025 Mar 25;26(7):2981. doi: 10.3390/ijms26072981.
7
F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance.F-box蛋白22:一种与免疫浸润和化疗耐药相关的结肠癌预后生物标志物。
World J Gastrointest Oncol. 2025 Apr 15;17(4):102913. doi: 10.4251/wjgo.v17.i4.102913.
8
FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature.FBXO22基因缺陷定义了一种与独特表观遗传特征相关的生长受限和多系统异常的多效性综合征。
Am J Hum Genet. 2025 May 1;112(5):1233-1246. doi: 10.1016/j.ajhg.2025.03.013. Epub 2025 Apr 10.
9
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner.SIRT7通过以雌激素依赖的方式调节PTEN稳定性来促进子宫内膜癌进展。
Nat Commun. 2025 Mar 27;16(1):2989. doi: 10.1038/s41467-025-58317-0.
10
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins.靶向泛素连接酶以稳定肿瘤抑制蛋白的治疗前景
Cancers (Basel). 2025 Feb 13;17(4):626. doi: 10.3390/cancers17040626.
Grb2 与 PTEN 结合,调节其核转位,以维持 DNA 损伤反应中的基因组稳定性。
Cell Death Dis. 2019 Jul 18;10(8):546. doi: 10.1038/s41419-019-1762-3.
4
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.Nrf2 激活通过抑制 Bach1 的降解促进肺癌转移。
Cell. 2019 Jul 11;178(2):316-329.e18. doi: 10.1016/j.cell.2019.06.003. Epub 2019 Jun 27.
5
FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.FBXO22 介导 LKB1 的多泛素化和失活,从而促进肺癌细胞生长。
Cell Death Dis. 2019 Jun 19;10(7):486. doi: 10.1038/s41419-019-1732-9.
6
Restoring tumor suppression.恢复肿瘤抑制作用。
Science. 2019 May 17;364(6441):633-634. doi: 10.1126/science.aax5526.
7
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.通过抑制 MYC-WWP1 抑制途径来激活 PTEN 肿瘤抑制因子以进行癌症治疗。
Science. 2019 May 17;364(6441). doi: 10.1126/science.aau0159.
8
PTEN arginine methylation by PRMT6 suppresses PI3K-AKT signaling and modulates pre-mRNA splicing.PRMT6 通过使 PTEN 精氨酸甲基化来抑制 PI3K-AKT 信号转导并调节前体 mRNA 的剪接。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6868-6877. doi: 10.1073/pnas.1811028116. Epub 2019 Mar 18.
9
SIRT4 regulates PTEN stability through IDE in response to cellular stresses.SIRT4 通过 IDE 调控 PTEN 的稳定性以响应细胞应激。
FASEB J. 2019 Apr;33(4):5535-5547. doi: 10.1096/fj.201801987R. Epub 2019 Jan 16.
10
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.Fbxo22 介导的 KDM4B 降解决定了选择性雌激素受体调节剂在乳腺癌中的活性。
J Clin Invest. 2018 Dec 3;128(12):5603-5619. doi: 10.1172/JCI121679. Epub 2018 Nov 12.